phoenix meds logo
Register Now

BPC-157 Information & Coordination for Licensed U.S. Clinics

BPC-157 is a peptide that has been discussed in research and compounding settings. FDA has not approved a drug product containing BPC-157.

Phoenix Meds Inc. supports licensed healthcare organizations with documentation, credential review, and compliance-focused administrative coordination. We are not a pharmacy, manufacturer, prescriber, or dispensing entity.

What Clinics Should Know About BPC-157

BPC-157 should not be presented as an FDA-approved treatment.

FDA has identified limited safety information for BPC-157 and has raised concerns involving immunogenicity, peptide-related impurities, and characterization of the active pharmaceutical ingredient. FDA states that it does not have enough information to determine whether compounded BPC-157 would cause harm when administered to humans through the proposed routes of administration.

For that reason, this page does not make claims that BPC-157 improves healing, inflammation, gastrointestinal conditions, athletic recovery, or other clinical outcomes.

Licensed healthcare professionals should rely on current FDA information and their own clinical, regulatory, and legal review when evaluating an investigational substance.

Contact Our Coordination Team
bpc-157 vial

Current FDA and Compounding Status

BPC-157 free base and BPC-157 acetate were reviewed by FDA in 2026 as part of the process for considering substances for the section 503A Bulks List.

FDA’s materials state that neither form has an applicable USP or National Formulary drug-substance monograph and neither is a component of an FDA-approved drug.

The substances were considered by the Pharmacy Compounding Advisory Committee in July 2026. That advisory process is not, by itself, a final agency determination, so clinics should check the current FDA status rather than relying on older supplier or website statements.

Phoenix Meds Inc. does not use a pharmacy’s 503A or 503B status as evidence that BPC-157 may lawfully be compounded in a particular situation.

Request Administrative Review

How Phoenix Meds Supports Licensed Clinics

Our work centers on the administrative side. A licensed healthcare organization may need help organizing documentation, checking publicly available licensing or regulatory information, or understanding which questions still need to be addressed before it makes its own decision. Our support may include:
  • clinic and provider credential review;
  • organization of supporting documents;
  • review of publicly available regulatory records;
  • administrative communication between professional entities; and
  • identification of issues that may need review by the clinic, pharmacy, regulatory professional, or legal counsel.
This helps reduce administrative back-and-forth while keeping each party’s role clear. Phoenix Meds Inc. does not make the clinical or legal decision for the clinic, and an administrative review is not a representation that a particular product or transaction is permitted.

Documentation and Due Diligence

Information concerning BPC-157 should be checked against current regulatory records and documentation relevant to the substance and parties involved.

We do not manufacture, test, compound, dispense, ship, or take custody of BPC-157 and do not certify its purity, potency, sterility, authenticity, safety, or clinical suitability.

Regulatory status can change. Clinics should verify current information before relying on it.

Speak With Our Coordination Team

BPC-157 Administrative Coordination for Licensed Clinics

Licensed U.S. healthcare organizations may contact Phoenix Meds Inc. about credential review, documentation, and our administrative process. An inquiry is not a medication order and does not establish product availability, compounding eligibility, clinical appropriateness, or approval of a proposed transaction.

Clinic Verification

Licensed healthcare organizations may submit relevant professional and facility credentials for administrative verification.
Register to Get Verified

Documentation Review

After verification, a clinic may request review of the documentation and regulatory information relevant to its inquiry.
REQUEST ADMINISTRATIVE REVIEW

Licensed Parties

Any prescribing, compounding, dispensing, distribution, shipping, storage, or other regulated medication activity remains with the party legally authorized and responsible for performing it.
Handled By Licensed Entities

Frequently Asked Questions

No FDA-approved drug product containing BPC-157 has been identified in FDA’s current review materials. FDA’s 2026 materials also state that BPC-157 free base and BPC-157 acetate are not components of FDA-approved drugs.
FDA reviewed BPC-157 free base and BPC-157 acetate in 2026 as part of the process for considering substances for the 503A Bulks List. Clinics should verify the current FDA status before relying on a compounding pathway because advisory-committee consideration is not itself a final agency determination.
No. A pharmacy’s status does not, by itself, establish that a particular bulk substance or preparation satisfies the applicable compounding requirements.
No. We do not compound, manufacture, dispense, test, ship, or take custody of BPC-157.
We provide administrative support around credential review, documentation, publicly available regulatory information, and professional communication.
No. We do not provide patient-specific dosing, treatment protocols, or clinical recommendations.
No. We do not test BPC-157 or certify its purity, potency, sterility, authenticity, safety, or clinical suitability.
Read More

Important Notice

Phoenix Meds Inc. provides administrative coordination, documentation, and compliance-focused support for licensed healthcare entities.

We are not a pharmacy, medical practice, manufacturer, outsourcing facility, prescriber, or dispensing entity.

This page is intended for professional informational purposes. It is not medical or legal advice, does not represent BPC-157 as an FDA-approved treatment, and does not establish that a particular compounding or distribution pathway is legally available.

Regulatory References

Scroll to Top

Thank You!

Your order has been placed successfully.

Order Number #14327
Date May 19, 2025
Payment Method Credit Card (Stripe)
Please look out for an email from FedEx when your order ships.
Continue Shopping  ›